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Objectives. To evaluate the efficacy of stent placement after infrainguinal loco-regional thrombolysis and iliac thrombec-
tomy (surgical TT) of acute deep vein thrombosis (DVT) in patients with May-Thurner-Syndrome.
Material and methods. We retrospectively analysed a group of 11 patients (9 women) (mean age 34 years, range 16e64
years) with surgical TT and additional intra-operative stenting due to compression of the common iliac vein. Patients
underwent venography to demonstrate outflow patency after surgical TT, and to identify any obstruction at the level
of the left-sided common iliac vein (‘‘Beckenvenen-Sporn’’). Obstruction at the level of arterial crossing was treated using
Wallstents placed via an introducer sheath from the inguinal access site. Stents were fully deployed using balloons
adjusted to the size of vein. Patients were treated with oral anticoagulants for 6 months, and followed using duplex
ultrasonography.
Results. Technical success defined as complete vein patency and normal valve function was documented in all 11 patients.
One patient needed early stent extension due to residual stenosis. At 6 months follow-up one patient (9%) had an asymp-
tomatic occlusion of the stented common iliac vein. In all 11/11 (100%) patients the femoral segment was found to be
patent, and in 1/11 (9%) there was mild reflux with few clinical symptoms of post-thrombotic syndrome. The calculated
cumulative primary patency rate for venous iliac stents was 82%, and assisted patency rate was 91%, which remained
unchanged over a mean follow-up of 22 months.
Conclusion. Combining surgical TT and stenting of common iliac vein obstructions in DVT is safe, effective, and results
in a acceptable venous patency.
Keywords: May-Thurner-Syndrome; Acute vein thrombosis; Venous stenting; Thrombolysis; Thrombectomy.Introduction
Compression of the left common iliac vein by the
overriding common iliac artery, as described by May
and Thurner for the first time in 1956, may cause ipsi-
lateral leg oedema, pain or deep vein thrombosis
(DVT).1,2
Anticoagulation does not prevent recurrent throm-
bosis after surgical thrombectomy and may cause
post-thrombotic syndrome with life long physical im-
pairment in up to 73% of patients with venous spur.3
A recent study described results of catheter-guided
thrombolysis and angioplasty with (n¼ 18) or without
stenting (n¼ 3) of the compressed common iliac vein.
Angioplasty and stenting of the iliac vein resulted in
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alone resulted in re-occlusion in all patients.4 Hence,
additional stenting of the venous spur has been
shown to be feasible and safe, and might improve
the long-term outcome in patients after thrombectomy
or thrombolysis of left-sided acute DVT.4e6
Systemic and catheter-guided thrombolysis in-
crease the risk of major haemorrhage when high doses
of thrombolytic drugs are used. Thrombectomy may
lead to valve destruction and venous incompetence.
Surgical thrombectomy of the iliac veins combined
with loco-regional thrombolysis of veins below the
groin after circulatory exclusion (surgical TT) has
been shown to result in a low rate of bleeding compli-
cations, therefore this is the preferred revasculariza-
tion technique today.4,7,8
This clinical series assesses the feasibility of addi-
tional stenting of the common iliac vein as a combined
intervention with surgical TT in a subset of patients
with acute DVT and documented venous spur.rved.
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Criteria for patient selection and patient population
Since 2000 we have considered patients with severely
symptomatic, extensive proximal DVT for combined
surgical TT and endovascular stenting when there is
potential for full restoration of patency in thedeepveins
and no contraindication to surgical or thrombolytic
treatment. Stenting is indicated for compression of the
common iliac vein demonstrated by intra-operative
venography at the end of surgical TT. Patients included
in this series typically had a short history of symptoms
(<1 week) and were experiencing their first episode of
DVT. The diagnosis was established by colour duplex
ultrasound imaging or venography. Written informed
consent was obtained from all patients.
Interventional technique
Stent placement was performed in the operating
theatre by cooperation between the vascular surgeon
and interventional angiologist. All patients were
treated under general anaesthesia, receiving positive
pressure mechanical ventilation in order to decrease
the risk of pulmonary embolisation. Inferior cava filter
devices were therefore not used. The operative field
was prepared under sterile conditions and venous ac-
cess was obtained via the left femoral vein. The left leg
was excluded from systemic circulation with a tourni-
quet cuff placed around the thigh at a pressure of
300 mmHg. Urokinase HS 500,000 IU was infused
together with 5000 U of unfractionated heparin with
additional saline solution via a dorsal foot vein. The
solution was distributed by manual leg massage and
thereafter allowed to act for 30 minutes. Meanwhile
the common femoral vein was exposed and the prox-
imal veins were cleared with a Fogarty Catheter using
a standard technique.7 The femoral vein was clamped
and the tourniquet removed. The thrombi were
flushed out by distal to proximal compression and
venous backflow. The venotomy was closed and an
8F-sheath introduced. Venography was performed to
assess the patency of iliac veins and to identify venous
compression via a left femoral vein sheath. Where
venography showed iliac vein compression, the pro-
posed proximal limit of the stent at the junction
of both common iliac veins was marked by venogra-
phy from a right femoral vein puncture (4-French
sheath). Over a guide-wire a stent typically sized
between 10 to 14 mm in diameter and 40 to 60 mm
long (Wallstent, Boston Scientific, Corporate, MA,
U.S.A) was placed in the left common iliac vein.Eur J Vasc Endovasc Surg Vol 34, July 2007Before deployment further venography was per-
formed to prove correct placement of the stent. After
deployment, dilation of the stent was achieved by
angioplasty using balloons 10/40 mm to 14/60 mm
in size (Fox, Abbott Vascular Laboratories, Abbott
Park, Illinois, U.S.A). Construction of an additional
arterio-venous fistula was left to the discretion of the
vascular surgeon.
Post-interventional procedure and follow-up
After the intervention all patients were fully anticoa-
gulated using standard heparin for twelve hours, sub-
sequently replaced by low molecular weight heparin
and oral coumarins. The dose of coumarin was ad-
justed to achieve an International Normalised Ratio
(INR) of 2-3 for a period of 6 months. Follow-up
was by clinical examination and by means of colour
duplex ultrasound imaging within the first 3 days fol-
lowing the intervention and after three, six, twelve
and 24 months. Clinical examination included assess-
ment of signs and symptoms related to DVT and
post-thrombotic syndrome. These data were used to
calculate the Villalta score.9 This score is the only
one that has been evaluated for evaluating the post-
thrombotic syndrome and integrates 5 symptoms
(pain, cramps, heaviness, pruritus, parasthesia) and
6 signs (oedema, sclerosis, pigmentation, venous ecta-
sia, redness, pain on manual pressure) graded into
slight (1 Point¼mild, 2 point¼moderate, 3 points se-
vere). Scoring 1 to 4 points means no post-thrombotic
syndrome, 5 to 14 mild/moderate PTS and more
than 15 points or ulcer reflects severe PTS. Duplex
findings were subdivided into complete patency
(vein compressibility, cardiac and respiratory phasic-
ity), changes of the venous wall and reflux. Reflux
was assessed in the femoral and popliteal veins and
defined as retrograde flow lasting more than 0.5 sec
following release of manual compression of the calf
muscles.
Results
Between 2000 and 2005, twelve patients were consid-
ered for combined surgical TT and stenting of venous
spur. One patient was not included in this retrospec-
tive study as compression of the common iliac vein
was caused by an uterus myomatosous. The study
population consists of two male and nine female
patients with a mean age of 34 (range 16 to 64) years
(Table 1). All patients had a first episode of DVT invol-
ving the iliac-femoral (n¼ 2), iliac-popliteal (n¼ 1) or
iliaco-tibial level (n¼ 8). All patients were treated
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.by loco-regional thrombolysis of femoro-tibial vein
thrombosis, surgical thrombectomy of iliac veins and
additional stenting of the common iliac vein. In seven
of eleven patients (63%) an arterio-venous fistula in
the groin was constructed. Mean time of hospitalisa-
tion was 8 (range 4 to 14) days. Average operation
time was 150 minutes (range from 110 to 240 minutes).
Procedural results
After surgical TT, successful stenting was performed
with complete restoration of vein diameter and nor-
mal valve function in 11/11 (100%) patients. Neither
major bleeding nor other significant complication
occurred in any patient.
In hospital outcome
Within one week after treatment one patient had an in-
stent stenosis of the common iliac vein as well as distal
to the stent and underwent percutaneous angioplasty
and stent extension. There was no major haemorrhage
in our study population. One complication which was
probably related to the surgical incision in the groin
was a peripheral sensory nerve lesion.
Mid-term outcome
At three and six months follow-up, 91% of patients had
no symptom or signs of post-thrombotic syndrome
(Villalta score 0). Duplex ultrasonography revealed
no venous valve dysfunction or post-thrombotic
changes in these patients. One male patient reported
mild post-thrombotic symptoms with slight swell-
ing and feeling of heaviness in the evening (Villalta
score 3). He showed valve dysfunction in the femoro-
popliteal vein segment. In one female patient the iliac
vein re-occluded without causing symptoms. The
femoral and politeal veins were patent with competent
valves. The cumulative 6-month primary patency rate
and assisted patency rates for venous stenting of the
left common iliac vein due to a venous spur were
81% and 91% respectively.
Mean follow-up time was 22 months, ranging from
3 to 64 months. No patient with a follow up period of
more than 12 (mean 26 SD 17, range 12 to 64) months
showed any relevant changes in the Villalta Score
(n¼ 1: Villalta score 3, n¼ 8: Villalta score 0).
Long term follow-up (>12 months, n¼ 9) showed
discrete venous valve dysfunction in the femoro-
popliteal vein segment in one patient (11%) with
mild post-thrombotic symptoms, and in one other
patient an asymptomatic iliac vein re-occlusion wasEur J Vasc Endovasc Surg Vol 34, July 2007
90 M. J. Husmann et al.found at 3 months follow-up. In seven patients the
stent was patent without stenosis and with normal
distal venous valve function.
Discussion
This retrospective analysis of prospectively collected
data indicates that stenting of the common iliac vein
in patients with acute DVT and May-Thurner-
Syndrome is feasible, and may improve patency after
surgical TT. A low rate of recurrent femoro-popliteal
thrombosis was observed with few post-thrombotic
symptoms. Post-thrombotic syndrome and recurrent
thrombosis are the most frequent problems encoun-
tered after a first episode of DVT and are related
to substantial morbidity and mortality.10 Up to 30%
of patients suffering from DVT will develop post-
thrombotic symptoms despite optimal medical treat-
ment and compression stockings.10 However, this
number is far greater in patients with acute DVT
caused by May-Thurner-Syndrome.3 Despite oral
anticoagulation and local compression, this selected
group of patients will have up to 70% recurrent
thrombosis and post-thrombotic symptoms.3 Subjects
with an anatomical compression of the left common
iliac vein by the left common iliac artery are prone
to develop proximal acute DVT due to stasis of
venous blood in the left leg.1,2,11,12 This has great
health-related and socioeconomic impact as these
patients are usually young and fit.13
Invasive therapywith catheter-guided thrombolysis
and angioplasty without additional stenting results in
a high recurrence rate of thrombosis up to 100%.4 In ac-
cordance to previous studies our results indicate that
primary patency of additional stenting of the common
iliac vein is above 80%, and development of severe
post-thrombotic syndrome is unlikely.5,8,14 Most im-
portant is the restored venous valve function of femo-
ral, popliteal and tibial veins, and although isolated
iliac vein thrombosis usually does not result in a severe
post-thrombotic syndrome, patency of this segment is
related to femoro-popliteal valve competence at least
during the initial phase after DVT.
Our approach is more invasive than other recently
described catheter-directed thrombolysis methods
without surgical thrombectomy, which achieve fa-
vourable clinical outcomes.5,8 In this series the authors
encountered one major bleeding complication with
a compartment syndrome of the forearm due to a pos-
sible radial artery injury after a venipuncture. Hae-
morrhage occurred during the thrombolytic therapy.
This demonstrates a major disadvantage of catheter-
directed thrombolysis which takes longer to achieveEur J Vasc Endovasc Surg Vol 34, July 2007its effect and leads to the risk of bleeding from the
systemic effects of thrombolysis. This risk is avoided
by our technique which does include the need for
a femoral venotomy, increasing the risk of haemor-
rhage and femoral nerve injuries.
The clinical picture of May-Thurner Syndrome is
not very well known, and the invasive approach
performed without stenting is not very effective at
achieving long term iliac vein patency.3 Long-term
follow-up data remains sparse. Treatment with low
molecular weight heparin enables ambulatory treat-
ment of DVT in most patients reducing the number
of patients referred to tertiary hospital care in recent
years.15 We acknowledge the limitations of this retro-
spective study as the number of patients is small and
the lack of long-term (5 to 10 year) follow up prevents
conclusions about the durability of this treatment.
Multicentre studies will be required to answer open
questions and to define optimal treatment.16 There
might be an immense impact on health and quality
of life in these patients as well as long-term socio-
economic costs despite higher initial costs of treat-
ment. We therefore call for a selective approach in
venous thrombosis of the lower limbs especially in
young patients with extensive thrombosis. We think
that the evaluation of an either catheter-directed or
surgical-interventional approach with stenting of a
venous outflow obstruction needs to be studied in
an randomised, open-label, multicentre trial.
In conclusion, our data suggests that stenting of the
iliac vein in presence of a iliac spur following surgical
thrombectomy of an ispilateral thrombosis is feasible,
reduces the risk of recurrent thrombosis, shows
a good patency rate and a favourable clinical outcome
by reducing post-thrombotic complications.
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